China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Globe Newswire (Wed, 5-Aug 9:00 AM ET)
Market Chameleon (Mon, 27-Jul 6:29 AM ET)
Globe Newswire (Fri, 24-Jul 5:30 PM ET)
China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering
Globe Newswire (Thu, 23-Jul 8:45 AM ET)
SXTC to Execute 1-for-150 Share Consolidation: What This Means for Investors
Market Chameleon (Mon, 2-Feb 4:53 AM ET)
Market Chameleon (Thu, 8-Jan 5:30 AM ET)
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
China Sxt Pharmaceuticals - Class A trades on the NASDAQ stock market under the symbol SXTC.
As of August 28, 2026, SXTC stock price declined to $3.10 with 70,498 million shares trading.
SXTC has a beta of 2.24, meaning it tends to be more sensitive to market movements. SXTC has a correlation of 0.00 to the broad based SPY ETF.
SXTC has a market cap of $1.66 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, SXTC traded as high as $83,758.76 and as low as $3.08.
SXTC has underperformed the market in the last year with a price return of -100.0% while the SPY ETF gained +20.0%. SXTC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -97.5% and -6.1%, respectively, while the SPY returned +2.7% and -1.2%, respectively.
SXTC support price is $2.61 and resistance is $4.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SXTC shares will trade within this expected range on the day.
